![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » NEW ZEALAND EXTENDS MENINGOCOCCAL IMMUNIZATION CAMPAIGN
NEW ZEALAND EXTENDS MENINGOCOCCAL IMMUNIZATION CAMPAIGN
April 13, 2006
New Zealand's meningococcal B immunization program, which uses Chiron's MeNZBT
vaccine, has been extended following successful results. Speaking at a celebration
to mark the delivery of the three millionth vaccine dose, New Zealand minister
of health Pete Hodgson said that new data confirms that the end of the meningococcal
B epidemic is in sight.
Pharmaceutical
Business Review
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct